StartUp Health Raises $31M From Novartis, Ping An Group, Chiesi Group, GuideWell and Otsuka

StartUp Health Closes Second Fund to Invest in Companies Focused on Achieving Health Moonshots

September 25, 2018 — New York, NY & San Francisco, CA — StartUp Health, a global organization dedicated to investing in entrepreneurs working to achieve health moonshots, announced today that it has closed its second fund, raising $31M. Investors include Novartis, Ping An Group, Chiesi Group, GuideWell, Otsuka, Masimo and a collaboratory of strategic partners, entrepreneurs, industry executives and private investors.
StartUp Health Transformer Fund II will invest in and support companies around the world focused on health moonshots. Following the success of StartUp Health’s inaugural fund, which included 100 digital health companies, Fund II has already made multiple investments including Aver, Biome, CareDox, Cohero Health,, Human Longevity Inc., LifeDojo, Nightingale Health, and Zeel.
“We are excited to lend our support to StartUp Health and its important mission of improving health and wellbeing around the world,” said Dr. William H. Carson, president and CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). “At Otsuka, we believe in the power of collaboration to help find solutions to the complex challenges of improving mental health, and we are eager to support the entrepreneurs associated with StartUp Health.” Click here to read the full press release. Please note that if you click the link, you will be directed to another website.